Concepedia
Statistics
Publications
5
Citations
166
H-Index
Active since
2019
Affiliations
University of British Columbia(Current)
BC Cancer Agency
University of Calgary
Centre Hospitalier de l’Université de Montréal
Joshua Hoenisch is an author at University of British Columbia specializing in ovarian cancer, medicine, and pathology.
Top concepts
MedicinePathologyOvarian CancerOncologyGynecologyCell BiologyEndocrinologyOvarian AgingTumor BiologyCancer Biology
Publications per year
2019–2022
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
Marta Llauradó Fernández, Amy Dawson, Joshua Hoenisch et al. · Cancer Cell International · 2019 · 44 citations · Full text
Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma
Marta Llauradó Fernández, Amy Dawson, Hannah Kim et al. · Gynecologic Oncology · 2020 · 42 citations
Hormone Receptor Expression, Medicine, Hormonal Receptor +8
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability
Raunak Shrestha, Marta Llauradó Fernández, Amy Dawson et al. · Cancer Research · 2021 · 38 citations · Full text
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Dane Cheasley, Marta Llauradó Fernández, Martin Köbel et al. · npj Precision Oncology · 2022 · 27 citations · Full text
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
Marta Llauradó Fernández, E. Marielle Hijmans, Annemiek M.C. Gennissen et al. · Molecular Cancer Therapeutics · 2022 · 15 citations · Full text
Signaling Pathway, Meki Resistance, Epithelial Ovarian Cancer +14
1–5 of 5